Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Evotec SE. (3/27/20). "Press Release: Evotec Statement on COVID-19 (last updated 27 March 2020)". Hamburg.

Organisation Organisation Evotec SE (FSE: EVT, MDA X/TecDAX)
  Group Evotec (Group)
Product Product drug discovery services
     


Many of you have been asking us about the Coronavirus and its potential impact on Evotec and its affiliates.

The situation surrounding the global COVID-19 outbreak continues to be extremely dynamic and is evolving daily. Many national governments are taking steps to try and reduce the rate of the spread through various measures, including travel restrictions, reduction of public gatherings and school closures.

At Evotec, we are actively managing our operations to maintain business continuity while taking measures to protect the health and wellbeing of our employees, their families and the local communities in which they live and work. We have taken a number of steps to ensure the continued health and safety of our colleagues during this challenging time.

For example:

> Wherever we operate, our measures are fully in line with the guidelines and recommendations of the governmental authorities. Additionally, each site has a specific, dedicated team chaired by the respective Site Head to monitor the impact of the COVID-19 outbreak, and take action where necessary

> Where stipulated by local authorities, we have deployed a remote-work model and where possible, individuals do their jobs from home

> We have surveyed our supply chain and are actively managing supplies to maintain business continuity

> We have locally tailored business continuity plans in place to anticipate and react appropriately, as the situation evolves territory-by-territory

We can confirm that at present Evotec continues to operate in all of our locations globally.

Our scientific teams are in close dialogue with their partners and are providing project-specific information on a real-time basis. Further information will of course be provided if the situation should change significantly, but at present, we are pleased to be able to maintain all our operations during this period.

   
Record changed: 2020-04-09

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Evotec (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top